Chester County News and Community Website
CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) announced robust fiscal second-quarter results for 2025, reporting a 10.3% year-over-year increase in revenue, reaching $75.5 billion. The company also posted notable earnings …
Cencora Reports Strong Q2 2025 Results, Raises Outlook Read More
WILMINGTON, DE — The Chemours Company (NYSE: CC) has released its financial results for the first quarter of 2025. The company reported net sales of $1.4 billion, consistent with the …
Chemours Reports Q1 2025 Financial Results, Highlights Strategic Initiatives Read More
CONSHOHOCKEN, PA — AdaptHealth Corp. (NASDAQ: AHCO) has announced its financial results for the first quarter of 2025, reporting a mixed performance as the company navigates an external environment marked …
AdaptHealth Reports First Quarter 2025 Financial Results, Updates Guidance Read More
PHILADELPHIA, PA — Aramark (NYSE: ARMK) delivered solid results in the second quarter of fiscal 2025, driven by robust operational performance, record client retention rates, and strategic growth initiatives. The …
Aramark Reports Strong Second Quarter 2025 Results, Reaffirming Fiscal Year Outlook Read More
NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) reported strong first-quarter 2025 financial results, posting revenue of $1.302 billion, an 11.7% increase year-over-year. The company also raised its full-year revenue …
EPAM Systems Announces Strong Q1 2025 Financial Results and Updated Revenue Outlook Read More
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) announced its financial results for the first quarter ended March 31, 2025, highlighting solid growth in the Branded Pharmaceuticals segment and the reaffirmation …
Endo, Inc. Reports First-Quarter 2025 Financial Results Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its first-quarter 2025 financial results and shared updates on its growing pipeline of gene therapy treatments aimed at combating significant unmet …
Ocugen Reports Progress in Q1 2025 with Advancements in Gene Therapy Read More
AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has announced its financial results for the first quarter of 2025, reporting revenue of $598.1 million, a decline of 1.4% compared to …
Globus Medical Reports Q1 2025 Results, Maintains Growth Outlook Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported a strong start to 2025, with first-quarter revenue reaching $18.5 million, a 12% increase compared to the same period last year …
TELA Bio Reports Q1 2025 Growth and Product Expansion Read More
WILMINGTON, DE — Acorn Energy, Inc. (OTCQB: ACFN) posted strong financial results for the first quarter of 2025, showcasing significant revenue growth driven by its major contract with a leading …
Acorn Energy Reports Q1 2025 Growth and Nasdaq Uplisting Plans Read More